Literature DB >> 20618771

Determination of kininogens levels and kallikrein/kininase II activities in patients with thromboangiitis obliterans.

R Dellalibera-Joviliano1, E E Joviliano, P R B Evora.   

Abstract

Some components of the kinin system such as plasma kallikrein levels, the activities of tissue kallikrein (including saliva) and kininase II and the concentrations of kininogen fractions (low-molecular weight/LKg and high-molecular weight/HKg) were evaluated in the plasma of patients with thromboangiitis obliterans (TAO) presenting clinical symptoms of the condition. Twenty TAO were diagnosed by means of the traditional Shionoya and Olin criteria and later classified into non-smokers (n = 11) and active smokers (n = 9). Fifty-three normal, non-smoking/smoking individuals (control) were also studied. Kininogen levels were determined by ELISA; the activities of kallikreins and kininase II were determined using selective substrates. The levels of enzymes (kallikreins and kininase II) and protein (kininogens) were significantly higher in patients with TAO who were active smokers compared to the control groups (no matter whether control individuals were active smokers or non-smokers, P < 0.001 for all comparisons). Interestingly, regardless of the time of disease onset, a significant increase in the levels of these components of the kinin system was also observed in patients when TAO active smokers were compared with TAO ex-smokers (P < 0.01 for all analysed parameters). Activation of the kinin system in patients with TAO may indicate the involvement of vasodilatation in an attempt to control vascular changes, thereby favouring the deposition of immune complexes at the vascular level because of nicotine stimulation. Moreover, our results corroborate the idea that TAO can be an autoimmune disorder with specific mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618771     DOI: 10.1111/j.1365-3083.2010.02408.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients.

Authors:  R Dellalibera-Joviliano; E E Joviliano; J S Silva; P R B Evora
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

2.  A benzimidazole inhibitor attenuates sterile inflammation induced in a model of systemic autoinflammation in female mice.

Authors:  Federica Agliano; Keaton S Karlinsey; Michael Ragazzi; Antoine Ménoret; Anthony T Vella
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

3.  Cilostazol on the expression of ICAM-1, VCAM-1 and inflammatory factors in plasma in patients with thromboangiitis obliterans.

Authors:  Fuchen Song; Bo Ji; Ting Chen
Journal:  Exp Ther Med       Date:  2018-07-11       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.